APC/Cyanine7 anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_APCCy7_060308
C57BL/6 splenocytes stained with RA3-6B2 APC/Cyanine7
  • RA3-6B2_APCCy7_060308
    C57BL/6 splenocytes stained with RA3-6B2 APC/Cyanine7
See APC/Cyanine7 spectral data
Cat # Size Price Quantity Avail. Save
103223 25 µg £55
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103224 100 µg £123
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse, Human, Cross-Reactivity: Cat (Feline)
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, and immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6.

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
Product Citations
  1. Petursdottir D, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01699. PubMed
  2. Uribe-Herranz M, et al. 2018. JCI Insight. 3. PubMed
  3. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  4. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  5. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  6. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  7. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  8. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  9. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  10. Lam WY et al. 2018. Cell reports. 24(9):2479-2492 . PubMed
  11. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  12. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  13. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  14. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  15. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  16. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  17. Xiao G, et al. 2018. Cell. 173:470. PubMed
  18. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  19. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  20. Roy K, et al. 2019. Immunity. 50:616. PubMed
  21. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  22. Whiteley AM et al. 2017. eLife. 6 pii: e26435. PubMed
  23. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  24. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  25. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  26. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  27. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  28. Sullivan JA, et al. 2020. Cell Rep. 30:1039. PubMed
  29. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  30. Wang YH, et al. 2019. Front Immunol. 10:1909. PubMed
  31. Yao M, et al. 2020. Cell. 180(3):502-520. PubMed
  32. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  33. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  34. Shinoda K, et al. 2020. Cell Reports. 29(13):4471-4481.e6.. PubMed
  35. Thayer T, et al. 2011. Diabetes. 60:2144. PubMed
  36. Sato-Hashimoto M, et al. 2011. J Immunol. 187:291. PubMed
  37. D'Auria K, et al. 2013. Infect Immun . 81:3814. PubMed
  38. Altin J, et al. 2014. Proc Natl Acad Sci U S A. 111:2067. PubMed
  39. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  40. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  41. Gough D, et al. 2014. Blood. 124:2252. PubMed
  42. Dema B, et al. 2014. J Exp Med. 211:2159. PubMed
  43. Huang Y, et al. 2015. Proc Natl Acad Sci U S A. 112:39. PubMed
  44. Chung Y, et al. 2014. J Vis Exp. 89: 51660. PubMed
  45. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  46. RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed
  47. Rodda L, et al. 2015. J Immunol. 195: 4781 - 4791. PubMed
  48. He Z, et al. 2016. Exp Hematol. 44:161-165. PubMed
  49. Muppidi J, et al. 2015. J Exp Med. 212: 2213 - 2222. PubMed
  50. Huang Y, et al. 2016. J Immunol. 196: 217 - 231. PubMed
  51. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  52. Palm A, et al. 2016. Sci Rep. 10.1038/srep20531. PubMed
  53. Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
  54. Jacoby E, et al. 2016. Blood. 127: 1361 - 1370. PubMed
  55. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  56. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  57. Jacoby E, et al. 2016. Nat Commun. 7:12320. PubMed
  58. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  59. Ishikura S, et al. 2016. J Biol Chem. 291: 15282 - 15291. PubMed
  60. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  61. Sochalska M, et al. 2016. Oncogene. 10.1038/onc.2016.362. PubMed
  62. BJ L, et al. 2017. J Exp Med . 10.1084/jem.20161461. PubMed
  63. Yan-Feng L, et al. 2017. Sci Rep. 7:40133. PubMed
  64. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  65. Wang X, et al. 2021. EMBO J. 40:e105926. PubMed
  66. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  67. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  68. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  69. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  70. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  71. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  72. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  73. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  74. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  75. Benet Z, et al. 2021. Cell Reports. 34(6):108733. PubMed
  76. Gonzalez-Figueroa P, et al. 2021. Cell. 184(7):1775-1789.e19. PubMed
  77. Mathew NR, et al. 2021. Cell Reports. 35(12):109286. PubMed
RRID
AB_313006 (BioLegend Cat. No. 103223)
AB_313007 (BioLegend Cat. No. 103224)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 04/25/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account